The Mumbai based pharmaceutical company Sun Pharmaceutical Industries Ltd, has received US FDA has approval for the Abbreviated New Drug Application (ANDA) to market a generic version of Forest Lab's Tessalon, benzonatate capsules.
Benzonatate USP capsules are therapeutically equivalent to Forest Lab's Tessalon, and are available in two strengths, capsules containing 100 mg and 200 mg benzonatate USP.
Benzonatate has annual sales of approximately US $40 million in the US.
Benzonatate is an antitussive, used to relieve cough due to the common cold, bronchitis, pneumonia, or other lung infections.
This product will reach market shortly. Tessalon is a registered trademark of Forest Laboratories, Inc.